Flora Growth Corp. has engaged Boustead Securities, LLC as its exclusive financial advisor. Further, the Company is pleased to announce it has surpassed US$28 million in funding and commitments processing in its ongoing Regulation A+ offering.
“As we look to close our Regulation A+ offering in the coming weeks, we are at an exciting and important point in the Company’s growth trajectory,” said Flora Growth’s CEO, Damian Lopez. “We believe Boustead’s experienced capital markets team will be able to advise us on the best path forward to grow Flora and maximize shareholder value. Given the success of our Regulation A+ offering, we believe the months ahead will be very positive for the Company.”
About Flora Growth’s Regulation A+ Offering
Flora Growth’s Regulation A+ offering has been open for 9 months out of a maximum of 24 months. During that period, Flora garnered investments of over US$28 million inclusive of both closed investments and commitments being processed and continues to work towards the potential maximum raise of US$30 million.
While Flora continues to see strong investment inflow, Flora expects to close the offering in the coming weeks as sufficient capital has been secured to execute on its immediate business plans. At this time, Flora anticipates using any additional capital to accelerate its growth and generate returns for all investors.
The use of funds from Flora’s Regulation A+ offering includes capital expenditures at the Cosechemos and Breeze Laboratory divisions, sales and marketing for Flora’s new brand portfolio, and general corporate and working capital provisions.
Boustead Securities, LLC is an investment banking firm that executes and advises on IPOs, mergers and acquisitions, capital raises and restructuring assignments in a wide array of industries, geographies and transactions, for a broad client base. Boustead’s core value proposition is the ability to create opportunity through innovative solutions and tenacious execution.
Flora is a vertically integrated cannabis company striving to be a globally recognized cannabis brand by leveraging low-cost production of cannabis to supply CBD oil to our portfolio of consumer and medical brands. Flora prioritizes organic ingredients and value-chain sustainability across its portfolio to create products that help consumers restore and thrive.